Spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD) is a rare autosomal 47 recessive disorder of the skeleton and the retina caused by biallelic variants in PCYT1A, encoding 48 the nuclear enzyme CTP:phosphocholine cytidylyltransferase α (CCTα), which catalyzes the rate-49 limiting step in phosphatidylcholine (PC) biosynthesis by the Kennedy pathway. As a first step in 50 understanding the consequences of PCYT1A variants on SMD-CRD pathophysiology, we 51 generated and characterized a series of cellular models for SMD-CRD, including CRISPR-edited 52 PCYT1A-null HEK293 and ATDC5 cell lines. Immunoblot and PC synthesis assays of cultured 53 skin fibroblasts from SMD-CRD patient cell lines revealed patient genotype-specific reductions in 54 CCTα steady state levels (10-75% of wild-type) and choline incorporation into PC (22-54% of 55 wild-type). While PCYT1A-null HEK293 cells exhibited fewer and larger lipid droplets in response 56 to oleate loading than their wild-type counterparts, SMD-CRD patient fibroblasts 57 (p.Ser323Argfs*38 homozygotes) failed to show significant differences in lipid droplet numbers 58 or sizes as compared to controls. Lipid droplet phenotypes in PCYT1A-null HEK293 cells were 59 rescued by transfection with wild-type, p.Ala99Val, and p.Tyr240His human PCYT1A cDNAs. 60 While both edited cellular models had normal morphology and proliferation rates compared to 61 unedited controls, Pcyt1a-null ATDC5 cells demonstrated accelerated rates of chondrocyte 62 differentiation as compared to their wild-type counterparts. Lipidomics revealed changes in 75-63 200 lipid levels in PCYT1A-null HEK293 and ATDC5 cells or in SMD-CRD patient fibroblasts as 64 compared to wild-type controls. The specific lipids altered and extent of change varied by cell 65 type. Importantly, both PCYT1A-null HEK293 cells and SMD-CRD patient fibroblast cell lines 66 had decreased phosphatidylcholine:phosphatidylethanolamine (PC:PE) ratios and decreased levels 67 of several lysophosphatidylcholine (LPC) species as compared to wild-type controls, suggesting 4 68 compensatory PC production through increased LPC remodeling by LPCAT or decreased 69 conversion of PC to LPC by phospholipase A 2 . Our results show that all tested PCYT1A alleles 70 associated with SMD-CRD are hypomorphic and suggest involvement of PCYT1A in chondrocyte 71 differentiation, PC:PE ratio maintenance and LPC metabolism, and lipid droplet formation. 72 Author Summary 73 Rare genetic disorders can reveal the function of genes on an organismal scale. When 74 normal gene activity is lost, patients can experience a range of symptoms, often dependent on the 75 residual activity of the encoded protein. Rare variants in the gene PCYT1A can cause multiple 76 inherited disorders, including a disorder of the skeleton and the retina characterized by short 77 stature, bone abnormalities, and blindness. PCYT1A is required for normal cellular function, 78 particularly lipid metabolism, but the role of this gene in human disease is still poorly understood. 79 To determine consequences of genetic variants in patients with this disorder, we made and studied 80 a series of cellular models, including cells cultured from patients and CRISPR-edited cell lines 81 lacking normal copies of PCYT1A. Here we show that patient variants lead to reduced PCYT1A 82 expression and/or function and have adverse consequences on cell biology and lipid metabolism 83 that are often cell-type specific. This work advances understanding of the role of lipid metabolism 84 in skeletal and eye development.
in response to demand for lipid synthesis or remodeling, or in response to requirements for lipid 163 droplet expansion in yeast, fly, and in multiple types of mammalian cells, including adult mouse 164 photoreceptors, hypertrophic zone chondrocytes from developing mouse growth plates, 165 hepatocytes, and adipocytes [13, 23, 24] . Most SMD-CRD variants are missense mutations in the 166 catalytic domain of the enzyme (Fig 2) , although two variants are in the M domain (p. In multiple species, cellular deficiency of CCTα orthologs results in formation of fewer 237 and larger lipid droplets than in control cells in response to oleate exposure [24, 27, 32, 33] . We 238 hypothesized that SMD-CRD patient fibroblast cells would have a similar phenotype in response 239 to oleate treatment. However, we found the sizes and numbers of lipid droplets in both wild-type 240 and SMD-CRD patient fibroblast cell lines were highly heterogeneous, and SMD-CRD patient 241 fibroblasts (p.Ser323Argfs*38 homozygotes) failed to show significant differences in lipid droplet 242 numbers or sizes as compared to control cells ( Fig 4A and 4C) . To assess the impact of total 243 PCYT1A deficiency we generated PCYT1A-null HEK293 cells (S2 Fig) . Interestingly, these cells 244 generated fewer and larger lipid droplets than their wild-type counterparts in response to oleate 245 loading ( Fig 4B and 4D) . Transfection with wild-type, p.Ala99Val, and p.Tyr240His PCYT1A 246 cDNAs rescued lipid droplet phenotypes in PCYT1A-null cells ( Fig 4E) . This result suggests that 247 either alleles with partial CCTα activity are sufficient to support normal lipid droplet morphology 248 in response to oleate loading in HEK293 cells, or that overexpression of these hypomorphic alleles 249 is sufficient for phenotypic rescue. number were quantified using "analyze particle" command in ImageJ (v1.47 Proliferation studies in HEK293 cells 265 Given the high concentration of PC in plasma membranes of cultured cells, we 266 hypothesized that CCTα deficiency would limit their proliferation. Interestingly, we found that 267 PCYT1A-null HEK293 cells proliferated at normal rates as compared to wild-type cells cultured 268 in standard medium supplemented with 10% FBS (Fig 5A) . To determine if this normal growth 269 rate was dependent on uptake of exogenous lipid from the medium, we also tested cells cultured Pcyt1a-null ATDC5 cells proliferated at normal rates as compared to their wild-type counterparts 291 ( Fig 5B) . Surprisingly, Pcyt1a-null ATDC5 cells differentiated into chondrocytes more quickly 292 than their wild-type counterparts ( Fig 6B) . sphingomyelin, or triacylglyceride. Some lipid classes were not represented in all cell lines tested.
312
In total, the levels of ~75-200 lipids were significantly changed in the PCYT1A-null or SMD-CRD 313 cells, and the specific lipids altered were largely variable depending on the cell type tested (S2 314   Table, S3 Table, S4 Table) . However, there were two significant changes in the lipidome shared 315 by both SMD-CRD cells and PCYT1A-null cells: reduced LPC content and reduced 316 phosphatidylcholine: phosphatidylethanolamine (PC:PE) ratios (Fig 7) .
317
The levels of several LPC species ( Fig 7A) were significantly decreased in PCYT1A-null 318 HEK293 cells (LPCs 16:1, 18:1, 18:2, 20:0, 20:3, 20:4, 20:5, 22:5, and 22:6) and in SMD-CRD HEK293 cells and in SMD-CRD patient fibroblast cell lines as compared to controls (Fig 7A) .
322
The reduction over all LPC classes attributed to loss of PCYT1A or the p.Ser323Argfs*38 mutation 323 was 3.3-fold for PCYT1A-null ATDC5 cells, 3.9-fold for PCYT1A-null HEK293 cells, and 1.7-324 fold for SMD-CRD fibroblasts. We also observed significant decreases in the 325 lysophosphatidylethanolamines (1.5-fold in null ATDC5 cells) and increases in 326 lysophosphatidylserines (2-fold in null HEK293 cells) (S2 Table, S4 Table) . PC:PE ratios were significantly reduced by 2-3 fold in PCYT1A-null HEK293 cells and in 338 SMD-CRD patient fibroblast cell lines as compared to their wild-type counterparts ( Fig 7B) . The
339
PC:PE ratio in PCYT1A-null ATDC5 cells was reduced, but the reduction was not statistically 340 significant. Because PC is a precursor to sphingomyelin (SM), we probed for relative and absolute 341 changes in the levels of SM and its metabolite, ceramide (Cer), which has been implicated in increase in diacylglycerol in SMD-CRD cells (S3 Table) , in line with a reduced rate of PC 346 synthesis. The PCYT1A-null HEK293 lipidome showed significantly increased 347 galactosylceramide and lactosylceramide (1.3-fold) (S4 Table) . associated with loss of membrane integrity, decreases in membrane potential, and membrane 446 packing defects due to increased proportions of conical lipids leading to increased membrane stress 447 [13, 38] . Our data suggest that decreased PC:PE ratios leads to adverse consequences in SMD-
448
CRD patients, perhaps in combination with the other defects we describe here.
449
The only lipid whose overall cellular content was decreased in two cell types was LPC, 450 which was present in lower proportions in PCYT1A-null HEK293 and ATDC5 cell lines as 451 compared to corresponding wild-type controls. In Pcyt1a-null ATDC5 cells, we also observed 452 decreases in overall LPE content, suggesting potential upregulation of LPE acyltransferase 453 (LPEAT) or downregulation of PLA 2 . In PCYT1A-null HEK293 cells, we observed decreased PC 454 content, suggesting that compensatory pathways for PC production may not be as robust in this 455 cell type. PCYT1A-null HEK293 cells also had increased content of LPS, galactosylceramide, and 21 456 lactosylceramide. The implications of increased levels of these lipids are unclear. Both 457 galactosylceramide and lactosylceramide are formed from ceramide, which can combine with PC 458 to form sphingomyelin in a reaction catalyzed by sphingomyelin synthase. It is possible that 459 decreased PC production by the Kennedy pathway depresses PC conversion to sphingomyelin in 460 an attempt to maintain cellular PC, which in turn shunts ceramide into galactosylceramide and 461 lactosylceramide production. In homozygous p.Ser323Argfs*38 fibroblasts, the proportions of 462 DAG and PE were increased as compared to wild-type fibroblasts. We expected increased 463 proportions of DAG, given that SMD-CRD cells have decreased production of CDP-choline, 464 which normally combines with DAG to form PC in the final step of the Kennedy pathway.
465
However, increased proportions of PE were not expected a priori. The increase in PE content could 466 result from shunting the DAG that is non-utilized for PC synthesis into the CDP-ethanolamine 467 pathway. We suggest that in SMD-CRD fibroblasts, upregulation of the PEMT pathway is not a 468 major means for compensatory PC production.
469
In addition, we found that several LPCs were significantly decreased in both PCYT1A-null 470 HEK293 and SMD-CRD patient fibroblast cell lines as compared to the corresponding control cell 471 lines. Decreased LPCs could be attributable either to increased conversion of LPC into PC by 472 LPCAT or to decreased conversion of PC into LPC by PLA 2 (Fig 1) . The former mechanism is 473 supported by recent work by Lee and Ridgway (2018), who showed rescue in lipid droplet 474 phenotypes in PCYT1A-null Caco2 cells supplemented with LPC [33] . Previous studies in COS 475 cells and in CHO cells have shown that CCTα overexpression increases LPC levels by promoting 476 PLA 2 -mediated PC catabolism [39, 40] . It is possible that decreased activity by this pathway is also 477 responsible for decreases in LPC in our cell lines.
Interestingly, recent studies have also demonstrated increased Lpcat4 mRNA expression
